Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
A NA clinical study on Iron-deficiency and Obesity, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 9 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Feb 2026 — Present [monthly]
Completed NA
-
Dec 2024 — Feb 2026 [monthly]
Completed NA
Status: Enrolling By Invitation → Completed
-
Sep 2024 — Dec 2024 [monthly]
Enrolling By Invitation NA
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation NA
-
Mar 2024 — Jul 2024 [monthly]
Enrolling By Invitation NA
▶ Show 4 earlier versions
-
Sep 2022 — Mar 2024 [monthly]
Enrolling By Invitation NA
Status: Recruiting → Enrolling By Invitation
-
Mar 2022 — Sep 2022 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Feb 2022 — Mar 2022 [monthly]
Not Yet Recruiting NA
-
Apr 2021 — Feb 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- National Heart, Lung, and Blood Institute (NHLBI)
- University of Illinois at Chicago
For direct contact, visit the study record on ClinicalTrials.gov .